Together we will beat cancerDonate
Breast cancer is the most common cancer in the UK, with around 55,200 people diagnosed each year. It starts in the breast tissue, most commonly in cells lining the milk ducts. Breast cancer predominantly affects women, but men can get it too.
New research from the ICR is showing us how additional measurements taken by MRI could speed up the development of new drugs that could make chemotherapies more effective
Olaparib, a targeted cancer drug discovered and developed with our funding, has been approved for hundreds of patients with certain breast and prostate cancers in England.
You may have heard about a new study into contraception and cancer. New information about cancer risks can be hard to apply to everyday life, so let’s break this research down and see what it means.
Lysa Jones, a golf coach and pro, talks about how her experiences in the sport helped her to cope with her breast cancer diagnosis.
Researchers have found a way to deliver cancer-killing viruses to tumours by hiding them inside immune cells.
Kizi and his wife Emma share the challenges they faced when he was diagnosed with a cancer that predominantly affects the opposite sex: a whirlwind of change and female-centred care.
A new study has revealed that Black women from Caribbean and African backgrounds are more likely to be diagnosed with certain types of cancer at later stages, when treatment is less likely to be successful.
Style vlogger Adobea Obeng decided to open up about her cancer diagnosis on her YouTube channel earlier this year.
The “potentially life-saving” immunotherapy drug pembrolizumab is now recommended for some people with early triple negative breast cancer in England and Wales.
It’s well known that exercise reduces cancer risk, but can it make any difference for people living with cancer? Read Mary and Keith’s stories.